Fullintel Logo
  • Solutions
    • Media Intelligence Platform
    • Executive News Briefings
    • Strategic Media Analysis
    • 24/7 Situation Management
  • By Need
    • Enterprise
    • PR Agencies
    • Government Services
  • Resources
    • Blog
    • PR Glossary
    • Newsroom
  • Customers
  • About
Client Login
Contact Us
Request Demo
Blog, Media Monitoring

Top Pharma News in February 2023

March 3, 2023 Eswari Vasudevan
Pharma Stories_FEB-min|Volume|Trending Rank|Reactions||

Google’s AI Medical Chatbot Draws Skepticism From Medical Professionals

Artificial Intelligence urges the pharma industry to reorganize business models and rationalize biopharma manufacturing as it enhances financial decisions and speeds up time-to-market. Furthermore, a new generation of AI reduces human error and boosts performance in the recent era, paving the way for a colossal advancement in the pharma industry. Through a synergistic interaction between various technologies, every step of the pharmaceutical value chain is benefiting from AI, including drug development, clinical trials, logistics, commercialization, marketing, and pharmacovigilance. Considering these metrics, our Fullintel Hub identifies the most trending topics and provides readers with an in-depth analysis of the top news impacting the pharmaceutical industry.

Coverage surrounding the following popular topics created a massive buzz in the industry this month: 

  • Google Research and DeepMind Develop AI Medical Chatbot
  • China’s Baidu to Release ChatGPT-Like Bot to Compete with Other Healthcare Bots
  • Biotech IPOs to Grow with a Focus on Startups With Human Trial Data

February’s Top Stories:

Google’s New Chatbot for Healthcare Grabs Media Attention

Coverage surrounding medical professionals expressing doubts over Google Research and DeepMind’s AI Medical ChatBot MedPaLM trended online and drove social engagement.

With over half of the coverage being neutral in sentiment, Google Research and DeepMind’s AI Medical ChatBot sparked a debate over its effectiveness, driving the highest trending scores for the analyzed period. Coverage featuring Chinese search engine Baidu’s plans to release its own ChatGPT-like bot to compete with other healthcare bots peaked during the first week of February and generated interest and discussion among industry experts, investors, and the public. Additionally, the news about small private biotech companies expected to see a resurgence in initial public offerings (IPOs) as interest rate hikes slow down garnered positive public reactions despite low coverage.

These topics contributed to about 7% of the overall coverage in the pharmaceutical industry.

A Break-Down of Recent Trending Stories:

Google Research and DeepMind Develop AI Medical Chatbot

While big tech companies have been playing around with large language models like GPT-3 and PaLM for quite a while, Google joins the game in response to Open AI’s ChatGPT by teaming up with DeepMind to develop MedPaLM. This ChatGPT-like Chatbot benchmarked on MultiMedQA is explicitly designed to answer medical questions, featuring methodology for evaluating human model responses across several axes, including factuality, precision, risk, and bias. Though “love” was the most dominant reaction by social media users, confirming that the news has generated excitement and optimism about the future of healthcare and the potential of AI to improve lives, it also sparked a significant number of “angry” responses due to the fear that artificial intelligence could take over jobs and override the advice of medical experts. This resulted in a 2% negative sentiment. Nevertheless, the story garnered significant attention in the pharma industry, and the coverage continued to trend throughout the month.

China’s Baidu to Release ChatGPT-Like Bot to Compete with Other Healthcare Bots

With Open AI’s ChatGPT turning AI technology on its head, Chinese tech giant and search engine leader Baidu is jumping on the bandwagon by preparing to launch its own ChatGPT-like AI tool “Wenxin Yiyan” (Ernie bot) in March. Additionally, by acquiring healthcare data provider GBI, Baidu is entering a new era of the “AI+Healthcare Big Data Whole Chain Insight” in healthcare as a part of launching this  bot. The acquisition is expected to provide significant growth opportunities for Baidu’s HCG in the healthcare sector, as GBI’s resources will enable Baidu to break traditional business models and achieve digital-intelligent transformation for corporate users, including pharmaceutical, medical equipment, CRO, or healthcare capital, in areas such as R&D, pipeline planning, market access, and commercialization. While the news received lots of “love” reactions, others feared its potential to take over jobs and produce biased or incorrect information, resulting in negative coverage. The coverage peaked on February 7 with a trending score of 5.

Biotech IPOs to Grow with a Focus on Startups With Human Trial Data

Initial public offerings by small private biotech companies are set to stage a comeback later in 2023 after a rough 2022 season. In the biotech sector, there were only 47 IPOs last year, raising a total of about $4 billion, compared to 152 offerings in 2021 that had raised over $25 billion. Despite Fullintel Hub recording a neutral sentiment for about three-quarters of this coverage, the news received a large share of  “love” and “wow” reactions from its audience. Additionally, the story garnered high trending scores on January 30 and February 13.

 

  • Media Monitoring
  • Pharma News
  • PR
  • Public Relations
Eswari Vasudevan
Eswari Vasudevan

Eswari Vasudevan is an AMEC-certified media intelligence expert who has more than 12 years of experience in automated and human-curated media monitoring. Her career was shaped by client delivery and leadership roles at organizations such as MyMediaInfo, Thomson Reuters, and Nasdaq. Currently based in Boston, Eswari is Senior Program Manager at Fullintel, guiding its customer base consisting of big Pharma and Fortune 1000 corporations. She remains committed to driving innovation in the media monitoring and measurement domain by implementing AI-aided crisis management and risk detection.

Post navigation

Previous
Next

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Blog 170
  • Business 37
  • campaign 1
  • Executive Insights 12
  • Marketing 7
  • Media Monitoring 156
  • Newsroom 16
  • Pharmaceutical News 20
  • PR Crisis 8
  • PR Lessons 4
  • PR Strategy 2
  • Press Release 8
  • Shows 2
  • Top media outlets 36
  • White paper 4

Recent posts

  • Media Alerts Arent Enough Anymore
    Alerts Ain’t What They Used to Be
  • Hidden Cost of DIY News Briefs in 2025
    Why Smart PR Teams Are Ditching DIY Media Monitoring in 2025: The Real Cost of Managing Your Own Executive News Briefs
  • Top Pharma Stories_June 2025
    Top Pharma News in June 2025

Tags

AI media monitoring AMEC AMEC Awards Angela Dwyer business intelligence ChatGPT Communications crisis communication Crisis Communications crisis management crisis media monitoring Crisis Monitoring Data and Measurement event media monitoring event monitoring influencer marketing influencer monitoring IPRRC Kamala Harris media analysis media intelligence media measurement Media Monitoring media monitoring platform media monitoring service media monitoring services Pharmaceutical News Pharma News PR PR Conferences PR Crisis PR crisis management PredictiveAI™ PR measurement PR news PR Research PRSA PRSA ICON PR Tools Public Relations real-time media monitoring Sentiment Analysis social listening social media monitoring social media platforms

Related posts

June's Top Pharma News
Pharmaceutical News

Top Pharma News: June 2025’s Game-Changing Developments Shaping Healthcare’s Future

June 25, 2025 Ted Skinner

The pharmaceutical industry continues its rapid evolution in June 2025, with breakthrough approvals, global market expansions, and multi-billion-dollar acquisitions reshaping the healthcare landscape. These developments signal fundamental shifts in how we approach cancer treatment, weight management, and international health access, each presenting unique challenges and opportunities for communications professionals. 1. FDA Approves Datroway for Lung […]

How to Pitch to Healthcare Media in 2025
Blog, Media Monitoring

How to Pitch to Healthcare Media in 2025: Winning Strategies for Successful Coverage

June 24, 2025 Angela Dwyer

The Evolving Healthcare Media Landscape What’s the best way to get a busy healthcare reporter’s attention in 2025? What topics interest biopharma journalists most this year? How can you ensure your healthcare pitch stands out in an increasingly competitive digital environment? As the healthcare industry continues to evolve rapidly, so do the strategies for effectively […]

AI Crisis Monitoring
Newsroom

Fullintel’s James Rubec Featured in Crisis Response Journal’s Summer 2025 Edition

June 13, 2025 Ted Skinner

We’re excited to share that James Rubec, Vice President of Products at Fullintel, has been featured in the latest edition of the Crisis Response Journal (CRJ), a leading publication in crisis management and resilience. Recognition for AI Innovation in Threat Detection In the Summer 2025 edition, James contributes valuable insights on AI-driven threat detection and […]

Fullintel Logo

Schedule time with a media expert to see a live, one-on-one demo.

  • 1.339.970.8005
  • Book a Demo
  • LinkedIn
  • Facebook
  • X
Solutions
  • Media Intelligence Hub
  • Executive News Briefings
  • Strategic Media Analysis
  • 24/7 Situation Monitoring
By Need
  • Enterprise
  • PR Agency
  • Government
Resources
  • Blog
  • Product Updates
  • Case Studies
Want to receive news and updates?

    © FullIntel, LLC. All Rights Reserved.

    • Terms & Conditions
    • Privacy Policy